In a new BBC interview, Sir Chris Hoy, six-time Olympic cycling champion, aged only 48, discussed his personal battle with terminal prostate cancer. Since his diagnosis in September 2023, Sir Chris has shared his experiences to raise awareness about prostate cancer, contributing to a surge in NHS searches on the topic. Reflecting on the physical and emotional challenges, he revealed how he copes with chemotherapy through mental resilience and support from family. Remarkably, both he an...

Such a powerful testimonial, a must read... "Dear Sirs, I should have written this thank you note a long time ago, but I guess better late than never. Back in May 2022, you held a blood test session at Luton Town Football Club, and I attended. My Dad had died of prostate cancer because he avoided the issue - and that was not going to happen to me. I’d had a test at my doctors and was told I had an enlarged prostate - but nothing to worry about apparently. &nbs...

Menopause isn’t just a “hot topic”; it’s a significant life stage for millions of women globally, marking the end of their reproductive years. Yet, for many, it arrives with more questions than answers. Did you know that we offer a Female Hormones Test for menopause? What is Menopause?Menopause is a natural biological process that usually occurs between the ages of 45 and 55, signalling the end of menstrual cycles due to changes in hormone levels. While menopause is ...

The NHS is conducting a groundbreaking trial of a home-based spit test designed to assess prostate cancer risk, with a strong focus on addressing disparities affecting Black men, who face double the risk of prostate cancer compared to other groups. Developed by the Institute of Cancer Research, the test works by analysing DNA from saliva, identifying genetic markers linked to high prostate cancer risk. Previously, the saliva test in 2016 was limited to white people of European ancestry due ...

At GFCT, we are proud to have been largely involved in gaining over 138,000 signatures in collaboration with PCR for a petition that demands a national prostate cancer screening programme in the UK. We are now supporting the Proactive For Your Prostate campaign, asking you to take 2 minutes to contact your MP to ask for their support on this cause.  Today, we share a powerful message from Brian, who has stage 4 incurable prostate cancer.  “Hi I’m Brian, and I...

We are delighted to announce that Steve Beard has joined us at GFCT as a Trustee with effect from 10th October. Steve has been a supporter of the charity since 2004 and was active in promoting PSA testing in Atherstone in 2007/8. He brings a wide range of experience to the charity from his years as a businessman running his own successful buildings access company which required an in depth knowledge of health and safety requirements. He has also been involved in the comm...

We are excited to announce a close working relationship with Prostate Cancer Support who run a helpline for anyone who has been diagnosed with prostate cancer. "Prostate Cancer Support run a helpline to assist with any queries about prostate cancer. It's a patient-led helpline, all the helpliners being prostate cancer patients who are happy to share their personal experiences and knowledge.We can cover a range of things from 'how to get checked' to an overview of typic...

Unfortunately, many people face barriers when trying to access crucial health tests such as a PSA test through their GP, forcing them to seek help elsewhere.Paul Campbell, a 54-year-old from South London, shared his story of being denied a PSA test by his GP at 42. After years of persistence, he was finally diagnosed with prostate cancer at 49—despite having no symptoms. Had he not fought for the test, his cancer could have gone undetected until it was too late. His experience highlights t...

On Friday 30th August, GFCT sent out an email to all clients informing them of a new service Doctor Asif Naseem is offering.  The reason we are offering this service is because we receive between 6 and 10 calls a week from men who are having issues with their own doctors and are not receiving the proper medical pathway.  Since this service commenced, Dr Naseem has helped two men who had a RED score. Their scores were above the recommended NICE age-related score for ...

The TRANSFORM trial, launched by Prostate Cancer UK with a £42 million investment, is set to become the most significant prostate cancer screening study in over 20 years. The trial seeks to establish the most effective way to screen men for prostate cancer, aiming to make regular screenings a reality for those at risk, enabling early detection and potentially curative treatment.Key Highlights: Collaborative Effort: Backed by the NHS, the National Institute for Health and Care Research...